CTOs on the Move


 
uBiome is the leading microbial genomics company. We are pioneering a new era of microbiome-based precision medicine. We allow doctors, patients, and citizen scientists to learn about the human microbiome with unprecedented accuracy and speed.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

uBiome raised $26.62M on 11/02/2016
uBiome raised $83M on 09/21/2018

Similar Companies

Rocky Mountain Health Care Services

Rocky Mountain PACE is a healthcare organization that provides coordinated health care services for older adults through the PACE model of care (Program of All-Inclusive Care for the Elderly). Their mission is to improve lives, optimize wellness, and p...

TemPharma

TemPharma is a Plainsboro, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Moore Medical Corp.

Moore Medical Corp. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Farmington, CT. To find more information about Moore Medical Corp., please visit www.mooremedical.com

NexCura

NexCura is a Spring, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Trinity Health New England

Trinity Health - New England is an integrated health care delivery system comprised of world-class providers and facilities dedicated to the full spectrum of preventive, acute, and post-acute care, all delivered with the triple aim of better health, better care, and lower costs for our patient populations. In New England, our hospitals, walk-in clinics, medical offices, specialized facilities, affiliated institutions, and foundations serve a population of nearly 3 million people. As a dynamic part of Trinity Health, based in Livonia, Michigan, and one of the nation`s largest multi-institutional Catholic health care delivery systems, Trinity Health - New England is uniquely positioned to advance health care through alliances with the University of Connecticut School of Medicine, the Frank H. Netter MD School of Medicine at Quinnipiac University, and through our own research institutions dedicated to the development of primary care, new treatments for cancer and MS, and much more.